loading

Oramed Pharmaceuticals Inc (ORMP) 最新ニュース

pulisher
May 12, 2026

Oramed Pharmaceuticals stock (US68403P1003): Shares surged 7.98% to $2.30 - AD HOC NEWS

May 12, 2026
pulisher
May 12, 2026

TradingKey - TradingKey

May 12, 2026
pulisher
May 06, 2026

MSN Money - MSN

May 06, 2026
pulisher
May 01, 2026

ORMP News | ORAMED PHARMACEUTICALS INC (NASDAQ:ORMP) - ChartMill

May 01, 2026
pulisher
Apr 27, 2026

NNDM stock in focus: Nano Dimension pops a poison pill days after Oramed stake build-up - MSN

Apr 27, 2026
pulisher
Apr 24, 2026

ORMP Should I Buy - Intellectia AI

Apr 24, 2026
pulisher
Apr 23, 2026

ORMP (Oramed Pharmaceuticals) falls 2.84% after releasing Q4 2025 earnings with no prior analyst consensus estimates.Current Ratio - Xã Thanh Hà

Apr 23, 2026
pulisher
Apr 22, 2026

ORMP (Oramed Pharmaceuticals Inc.) rises 0.53 percent following release of its 2025 fourth quarter earnings results.Debt/Equity - Xã Thanh Hà

Apr 22, 2026
pulisher
Apr 16, 2026

Oramed Pharmaceuticals (ORMP) Stock Rally Stalls (+1.05%) 2026-04-16Shared Momentum Picks - Xã Vĩnh Công

Apr 16, 2026
pulisher
Apr 14, 2026

Oramed Pharmaceuticals And Two Other Promising Penny Stocks For Savvy Investors - Yahoo Finance

Apr 14, 2026
pulisher
Apr 13, 2026

Evolus and Oramed Pharmaceuticals Compared - National Today

Apr 13, 2026
pulisher
Apr 10, 2026

Setup Watch: Is Oramed Pharmaceuticals Inc stock technically oversold2026 Opening Moves & Daily Profit Focused Stock Screening - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 09, 2026

Sell Signal: What is Oramed Pharmaceuticals Incs 5 year growth outlookEarnings Overview Summary & AI Powered Trade Plan Recommendations - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 08, 2026

Fund Flows: Can Oramed Pharmaceuticals Inc keep up with sector leadersMarket Performance Summary & Safe Entry Momentum Stock Tips - baoquankhu1.vn

Apr 08, 2026
pulisher
Apr 08, 2026

Technical Analysis: Will Oramed Pharmaceuticals Inc face regulatory challenges2026 Earnings Impact & Growth Oriented Trading Recommendations - baoquankhu1.vn

Apr 08, 2026
pulisher
Apr 08, 2026

Lifeward scoops US$20M after completing Oratech Pharma takeover - Mugglehead Investment Magazine

Apr 08, 2026
pulisher
Apr 07, 2026

Oramed Pharmaceuticals (NASDAQ:ORMP) Share Price Passes Above 50-Day Moving AverageHere's What Happened - MarketBeat

Apr 07, 2026
pulisher
Apr 04, 2026

ORMP Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Apr 04, 2026
pulisher
Apr 03, 2026

Oramed Pharmaceuticals stock: Oral insulin pioneer or high-risk bet? - AD HOC NEWS

Apr 03, 2026
pulisher
Apr 03, 2026

INO Stock Analysis: Inovio Pharmaceuticals Inc. plunges 35% to $1.13 biotech support level - Xã Thanh Hà

Apr 03, 2026
pulisher
Apr 02, 2026

ORMP Q4 Earnings: Beats Estimates by $1.16 - newser.com

Apr 02, 2026
pulisher
Apr 01, 2026

Oramed Completes Oratech Sale and Strategic Lifeward Financing - The Globe and Mail

Apr 01, 2026
pulisher
Apr 01, 2026

ABOS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 01, 2026
pulisher
Mar 31, 2026

Oramed (ORMP) completes Oratech sale and buys $9M Lifeward notes - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

Oramed (NASDAQ: ORMP) CSO uses 435,084 shares to cover RSU tax - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

Oramed (NASDAQ: ORMP) CEO uses 44,818 shares to cover RSU tax withholding - Stock Titan

Mar 31, 2026
pulisher
Mar 30, 2026

FOMO Trade: Is Oramed Pharmaceuticals Inc stock good for income investorsMarket Sentiment Report & Entry and Exit Point Strategies - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 30, 2026

Oramed Pharmaceuticals Hits New 52-Week High of $3.76, Up 75% Yearly - Markets Mojo

Mar 30, 2026
pulisher
Mar 28, 2026

Oramed Pharmaceuticals (ORMP) price target increased by 92.31% to 6.38 - MSN

Mar 28, 2026
pulisher
Mar 27, 2026

Oramed Pharmaceuticals (NASDAQ:ORMP) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat

Mar 27, 2026
pulisher
Mar 27, 2026

Oramed Pharmaceuticals: Oral Insulin Technology, Strategic Investments, and 2026 Business Overview - Minichart

Mar 27, 2026
pulisher
Mar 26, 2026

Oramed: Q4 Earnings Snapshot - Barchart.com

Mar 26, 2026
pulisher
Mar 26, 2026

Oramed Pharmaceuticals 2025 10-K: $2.0M Revenue, $1.50 Diluted EPS - TradingView — Track All Markets

Mar 26, 2026
pulisher
Mar 26, 2026

Oramed (NASDAQ: ORMP) pivots with Lifeward deal and Alpha Tau stake - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

Lifeward closes Oramed partnership, secures $10 million funding By Investing.com - Investing.com Australia

Mar 26, 2026
pulisher
Mar 25, 2026

Lifeward Closes Oramed Partnership, Acquires Oratech Pharma - Moomoo

Mar 25, 2026
pulisher
Mar 25, 2026

Lifeward closes Oramed partnership, secures $10 million funding - Investing.com

Mar 25, 2026
pulisher
Mar 25, 2026

Lifeward Successfully Closes on Strategic Partnership with Oramed - manilatimes.net

Mar 25, 2026
pulisher
Mar 24, 2026

Lifeward Ltd. completed the acquisition of Oratech Pharma, Inc. from Oramed Pharmaceuticals Inc.. - marketscreener.com

Mar 24, 2026
pulisher
Mar 23, 2026

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Mar 23, 2026
pulisher
Mar 23, 2026

Oramed Pharmaceuticals Inc expected to post breakeven results a shareEarnings Preview - TradingView

Mar 23, 2026
$53.27
price up icon 0.74%
$51.70
price up icon 0.10%
$93.66
price up icon 0.34%
$116.00
price up icon 11.66%
$145.72
price up icon 1.09%
ONC ONC
$315.07
price up icon 1.39%
大文字化:     |  ボリューム (24 時間):